澳洋健康收盘下跌3.10%，滚动市盈率54.05倍，总市值26.34亿元

Core Viewpoint - Aoyang Health's stock closed down 3.10% with a rolling P/E ratio of 54.05 times and a total market capitalization of 2.634 billion yuan, indicating a decline in performance compared to industry averages [1][2]. Company Summary - Aoyang Health's main business focuses on health care, including pharmaceutical logistics, medical services, and health care services. The company operates four hospitals in Zhangjiagang City, with Aoyang Hospital recognized as a tertiary comprehensive hospital and JCI certified, enhancing its reputation in the health sector [1]. - The company achieved a revenue of 1.501 billion yuan in the latest quarterly report, reflecting a year-on-year decrease of 7.54%. The net profit was 38.6781 million yuan, down 2.39%, with a sales gross margin of 13.72% [2]. Industry Summary - The average P/E ratio for the medical services industry is 44.02 times, with a median of 43.09 times, positioning Aoyang Health at the 32nd rank within the industry [1][2]. - The company experienced a net outflow of 2.1705 million yuan in principal funds on March 24, with a total outflow of 73.5313 million yuan over the past five days, indicating a negative trend in investor sentiment [1].